Indonesian Students Achieve Success at The Hong Kong Polytechnic University
Join Our Event at the Pullman Jakarta Central Park on 23 March 2025 HONG KONG, March 10, 2025 /PRNewswire/ -- Choosing the right university is a pivotal decision for many students, given the numerous options and the competitive landscape. For two...
Next-Gen ProAV: Hikvision rolls out an evolving audio-visual ecosystem with digital innovations at ISLE 2025
HANGZHOU, China, March 10, 2025 /PRNewswire/ -- As an innovative industry pioneer, Hikvision has elevated ProAV by showcasing immersive experiences at ISLE 2025. This landmark demonstration reflects Hikvision's ongoing efforts to revolutionize...
Plus and TIER IV Partner to Advance Autonomy 2.0 in Japan, Starting with Driverless Trucks
TOKYO and SANTA CLARA, Calif, March 10, 2025 /PRNewswire/ -- Plus, a global leader in AI-based autonomous trucking software, and TIER IV, the pioneering force behind the world's first open-source software for autonomous driving, today announced a...
CrowdStrike Awarded with Frost & Sullivan's 2024 Company of the Year Award for SaaS Security Posture Management Leadership
CrowdStrike Falcon® Shield delivers industry-leading protection and control over SaaS misconfigurations, identities and threats – unifying hybrid identity protection SAN ANTONIO, March 10, 2025 /PRNewswire/ -- Frost & Sullivan has recognized...
Ubiqconn Joins Satellite 2025 to Showcase Cutting-Edge Satellite Communication Solutions
TAIPEI, March 10, 2025 /PRNewswire/ -- Ubiqconn Technology, a leading provider of industrial Internet of Vehicle (IoV) and embedded Internet of Things (IoT) solutions, is excited to announce its participation at Satellite 2025 in Washington DC, from...
Kelun-Biotech's TROP2 ADC Sacituzumab Tirumotecan (sac-TMT) Approved for Marketing in Second Indication by NMPA for EGFRm NSCLC
CHENGDU, China, March 10, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company's trophoblast cell-surface antigen 2 (TROP2)-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan...
Mitsubishi Motors Canada Launches AI-Powered "Intelligent Companion" to Transform the 2025 Outlander Buying Experience
LONDON, ARMONK, N.Y. and MISSISSAUGA, ON, March 10, 2025 /PRNewswire/ -- Mitsubishi Motor Sales of Canada announces an innovative AI-powered tool designed to transform the customer experience for the new Mitsubishi Outlander 2025. "The Intelligent...
GIGABYTE Elevates Immersive Content with AI and XR at SXSW 2025
Experience the Future of AI-Powered Creativity! GIGABYTE AI PCs Lead You to Explore New Frontiers TAIPEI, March 10, 2025 /PRNewswire/ -- GIGABYTE, a global leader in high-performance computing, partners with the Taiwan Creative Content Agency...